Skip to main content
TipRanks
Go Ultimate75% OFF

Top Page

DBEF

Xtrackers MSCI EAFE Hedged Equity ETF (DBEF)

Rating:65Neutral
Price Target:$60.00▲(7.07% Upside)

DBEF’s rating suggests it is a solid, but not top-tier, international equity ETF, helped by strong core holdings like HSBC, Novartis, and AstraZeneca, which show healthy financial performance and positive outlooks. These strengths are balanced by more mixed names such as SAP and Shell, where weaker technical trends, growth challenges, or valuation concerns limit their contribution. The main risk is that many top holdings are large non-U.S. financials and healthcare companies, so the fund is exposed to sector and regional developments in those areas.

Positive Factors
Strong Year-to-Date PerformanceThe ETF has delivered strong gains so far this year, showing solid overall momentum for investors.
Leading Global Blue-Chip HoldingsTop positions like ASML, Shell, and major European and Japanese banks and healthcare firms have generally performed well, supporting the fund’s returns.
Broad International DiversificationThe fund spreads its investments across many developed countries and sectors, helping reduce the impact of problems in any single market or industry.
Negative Factors
Recent Short-Term WeaknessPerformance over the last month and quarter has been slightly negative, suggesting some short-term pressure on the fund’s price.
Moderate Expense RatioThe fund’s fees are not extremely high but are also not among the very lowest, which slightly reduces the net return investors keep.
Exposure to Lagging HoldingOne of the larger healthcare holdings has been weak this year, which can modestly drag on overall performance if the trend continues.

DBEF vs. SPDR S&P 500 ETF (SPY)

-5%0%5%10%15%20%25%SPY+14.55%DBEF+21.73%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AUM
9.55B
Region
Developed Markets
Expense Ratio
0.35%
Beta
0.71
Issuer
Xtrackers
Inception Date
Jun 09, 2011
Dividend Yield
4.76%
Asset Class
Equity
Index Tracked
MSCI EAFE 100% Hedged to USD Net Variant

DBEF Summary

DBEF is an ETF that tracks the MSCI EAFE index, which covers large and mid-sized companies in developed markets outside the U.S. and Canada, such as Japan, the UK, and Europe. It owns many well-known international names like Nestlé and AstraZeneca, and it spreads your money across many sectors, helping with global diversification. A key feature is that it hedges currencies, aiming to reduce the impact of foreign exchange swings so you mainly follow stock performance. A simple risk to remember is that international stocks can still go up and down with global markets.

How much will it cost me?

This ETF has an expense ratio of 0.35%, which means you’ll pay about $3.50 per year for every $1,000 you invest. That’s a bit higher than the cheapest index ETFs because this fund adds a currency-hedging strategy on top of its passive index tracking, which increases costs slightly.

What would affect this ETF?

DBEF could benefit if developed markets in Europe and Asia grow steadily, especially in sectors like financials, industrials, and health care, and if its major holdings such as ASML, Roche, and HSBC perform well, while its currency hedging helps reduce the impact of a strong or volatile U.S. dollar. On the downside, slower global economic growth, banking or energy sector stress, or unfavorable regulations in key countries could hurt these international stocks, and the fund may lag unhedged peers if foreign currencies strengthen significantly against the dollar.

DBEF Top 10 Holdings

DBEF is leaning on a mix of European heavyweights, with ASML and SAP giving the fund a tech edge as both have been rising over the past few months, even if ASML has cooled a bit lately. Health care names like Roche and Novartis are steady engines, adding defensive strength with generally solid, upward trends. On the flip side, consumer giant Nestlé and pharma player AstraZeneca have been more mixed, occasionally losing steam and holding back returns. Overall, the ETF is diversified across sectors and focused on developed markets outside North America, with a clear tilt toward European blue chips.

DBEF top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
NL:ASMLNL:ASMLASML Holding NV2.63%$245.91MEUR 511.40B51.88%76Outperform
RHHVFRHHVFRoche Holding AG――――73Outperform
GB:HSBAGB:HSBAHSBC Holdings1.41%$132.04MGBP 231.98B20.93%80Outperform
CH:NOVNCH:NOVNNovartis AG1.34%$125.48MCHF 245.40B26.78%80Outperform
GB:SHELGB:SHELShell (UK)1.31%$122.35MGBP 210.62B30.08%73Outperform
AZNAZNAstraZeneca――――80Outperform
CH:NESNCH:NESNNestlé SA1.23%$115.47MCHF 225.64B8.18%71Outperform
DE:SAPDE:SAPSAP SE1.10%$102.42MEUR 249.22B-2.13%66Neutral
JP:8306JP:8306Mitsubishi UFJ Financial Group1.07%$99.82MJPY 39.11T41.84%76Outperform
DE:SIEDE:SIESiemens1.02%$95.65MEUR 212.98B23.08%74Outperform

DBEF Technical Analysis

Technical Analysis SentimentPositive
Last Price56.04

Price Trends

50DMA55.03Positive
100DMA55.14Positive
200DMA53.28Positive

Market Momentum

MACD0.21Negative
RSI58.28Neutral
STOCH95.23Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DBEF, the sentiment is Positive. The current price of 56.04 is above the 20-day moving average (MA) of 55.03, above the 50-day MA of 55.03, and above the 200-day MA of 53.28, indicating a bullish trend. The MACD of 0.21 indicates Negative momentum. The RSI at 58.28 is Neutral, neither overbought nor oversold. The STOCH value of 95.23 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DBEF.

DBEF Peer Comparison

Comparison Results

DBEF against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
DBEFDBEF$56.04$60.00(7.07% Upside)$9.55B0.35%65Neutral
BBINBBIN$78.10$91.95(17.73% Upside)$6.54B0.07%66Neutral
EFAVEFAV$96.91$101.95(5.20% Upside)$5.65B0.20%61Neutral
HFXIHFXI$36.61$45.19(23.44% Upside)$2.55B0.20%60Neutral
IHDGIHDG$53.10$62.85(18.35% Upside)$2.11B0.58%66Neutral
DDWMDDWM$46.50$52.60(13.13% Upside)$1.45B0.40%64Neutral

Performance Comparison

0%10%20%DBEFBBINEFAVHFXIIHDGDDWMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DBEF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DBEFXtrackers MSCI EAFE Hedged Equity ETF56.049.4720.33%
BBINJPMorgan BetaBuilders International Equity ETF78.109.9814.66%
EFAViShares MSCI EAFE Min Vol Factor ETF96.9114.1217.05%
HFXIIQ 50 Percent Hedged FTSE International ETF36.615.8418.98%
IHDGWisdomTree International Hedged Quality Dividend Growth Fund53.107.0515.30%
DDWMWisdomTree Dynamic Currency Hedged International Equity Fund46.505.5213.48%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.